80_FR_10533 80 FR 10495 - Center for Scientific Review; Notice of Closed Meetings

80 FR 10495 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 38 (February 26, 2015)

Page Range10495-10495
FR Document2015-03936

Federal Register, Volume 80 Issue 38 (Thursday, February 26, 2015)
[Federal Register Volume 80, Number 38 (Thursday, February 26, 2015)]
[Notices]
[Page 10495]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03936]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Fellowships: Risk, Prevention, and Health Behavior Overflow.
    Date: March 18, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Lee S. Mann, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3224, MSC 7808, Bethesda, MD 20892, 301-435-
0677, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Innate/Adaptive Immunology and Vaccine Development.
    Date: March 19-20, 2015.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Patrick K. Lai, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 
20892, 301-435-1052, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Fellowships: Risk, Prevention and Health Behavior.
    Date: March 23-24, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Martha M. Faraday, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 
20892, (301) 435-3575, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 20, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-03936 Filed 2-25-15; 8:45 am]
BILLING CODE 4140-01-P



                                                                                     Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices                                                                   10495

                                               burden of the collection of information                                    instruments, contact Dr. Diane Post,                            disease—a critical knowledge gap
                                               on those who are to respond, including                                     Program Officer, Respiratory Diseases                           impacting effectiveness of decision-
                                               the use of appropriate automated,                                          Branch, NIAID, NIH 5601 Fishers Lane,                           making around patient care. The 2014–
                                               electronic, mechanical, or other                                           Bethesda, MD or call non-toll-free                              15 influenza season is unique because
                                               technological collection techniques or                                     number at 240–627–3348 or email your                            the dominant circulating strain is an
                                               other forms of information technology.                                     request, including your address to:                             H3N2 strain that is not sensitive to the
                                                 Direct Comments to OMB: Written                                          postd@niaid.nih.gov                                             immunity induced by the influenza
                                               comments and/or suggestions regarding                                      SUPPLEMENTARY INFORMATION:                                      vaccine formulation administered to the
                                               the item(s) contained in this notice,                                        Proposed Collection: Human                                    general public. Our study will provide
                                               especially regarding the estimated                                         Influenza Surveillance of Health Care                           insight into viral determinants that may
                                               public burden and associated response                                      Centers in the United States and                                be contributing to the severity of
                                               time, should be directed to the: Office                                    Taiwan, (NIAID), 0925—NEW, National                             influenza and associated morbidity and
                                               of Management and Budget, Office of                                        Institute of Allergy and Infectious
                                               Regulatory Affairs, OIRA_submission@                                                                                                       mortality this season. Capturing samples
                                                                                                                          Diseases (NIAID), National Institutes of                        from this influenza season is essential
                                               omb.eop.gov or by fax to 202–395–6974,                                     Health (NIH).
                                               Attention: NIH Desk Officer.                                                                                                               for understanding the public health
                                                                                                                            Need and Use of Information
                                               DATES: Comment due date: Comments
                                                                                                                                                                                          implications the virus may have in the
                                                                                                                          Collection: This study will identify
                                               regarding this information collection are                                                                                                  future, and discerning the reasons
                                                                                                                          individuals with influenza through
                                               best assured of having their full effect if                                                                                                behind the severity of the disease it
                                                                                                                          focused surveillance in key regions of
                                               received within 7 days of the date of                                      the United States and Taiwan, rapidly                           causes.
                                               this publication.                                                          identify circulating influenza strains to                          OMB approval is requested for 6
                                               FOR FURTHER INFORMATION CONTACT: To                                        identify those with pandemic potential                          months. There are no costs to
                                               request more information on the                                            and create an invaluable bank of human                          respondents other than their time. The
                                               proposed project or to obtain a copy of                                    samples from patients with influenza to                         total estimated annualized burden hours
                                               the data collection plans and                                              characterize the basis of severe                                are 500.

                                                                                                                         ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                              Average
                                                                                                                                                                                          Number of
                                                                                                                                                                        Number of                           burden per      Total burden
                                                                                          Type of respondent                                                                            responses per
                                                                                                                                                                       respondents                           response          hours
                                                                                                                                                                                          respondent         (in hours)

                                               Patients ............................................................................................................         500              2               30/60              500



                                                 Dated: February 20, 2015.                                                  Name of Committee: Center for Scientific                        Date: March 23–24, 2015.
                                               Dione Washington,                                                          Review Special Emphasis Panel,                                    Time: 8:00 a.m. to 5:00 p.m.
                                                                                                                          Fellowships: Risk, Prevention, and Health                         Agenda: To review and evaluate grant
                                               Project Clearance Liaison, NIAID, NIH,                                     Behavior Overflow.
                                               NIAID, NIH.                                                                                                                                applications.
                                                                                                                            Date: March 18, 2015.                                           Place: Embassy Suites at the Chevy Chase
                                               [FR Doc. 2015–04069 Filed 2–25–15; 8:45 am]                                  Time: 8:00 a.m. to 5:00 p.m.
                                                                                                                            Agenda: To review and evaluate grant                          Pavilion, 4300 Military Road, NW.,
                                               BILLING CODE 4140–01–P
                                                                                                                          applications.                                                   Washington, DC 20015.
                                                                                                                            Place: National Institutes of Health, 6701                      Contact Person: Martha M. Faraday, Ph.D.,
                                                                                                                          Rockledge Drive, Bethesda, MD 20892,                            Scientific Review Officer, Center for
                                               DEPARTMENT OF HEALTH AND
                                                                                                                          (Virtual Meeting).                                              Scientific Review, National Institutes of
                                               HUMAN SERVICES                                                               Contact Person: Lee S. Mann, Ph.D.,                           Health, 6701 Rockledge Drive, Room 3110,
                                                                                                                          Scientific Review Officer, Center for                           MSC 7808, Bethesda, MD 20892, (301) 435–
                                               National Institutes of Health                                              Scientific Review, National Institutes of                       3575, faradaym@csr.nih.gov.
                                                                                                                          Health, 6701 Rockledge Drive, Room 3224,
                                               Center for Scientific Review; Notice of                                    MSC 7808, Bethesda, MD 20892, 301–435–                          (Catalogue of Federal Domestic Assistance
                                               Closed Meetings                                                            0677, mannl@csr.nih.gov.                                        Program Nos. 93.306, Comparative Medicine;
                                                                                                                            Name of Committee: Center for Scientific                      93.333, Clinical Research, 93.306, 93.333,
                                                 Pursuant to section 10(d) of the                                         Review Special Emphasis Panel, Innate/                          93.337, 93.393–93.396, 93.837–93.844,
                                               Federal Advisory Committee Act, as                                         Adaptive Immunology and Vaccine                                 93.846–93.878, 93.892, 93.893, National
                                               amended (5 U.S.C. App.), notice is                                         Development.                                                    Institutes of Health, HHS)
                                               hereby given of the following meetings.                                      Date: March 19–20, 2015.
                                                                                                                            Time: 8:30 a.m. to 5:00 p.m.                                    Dated: February 20, 2015.
                                                 The meetings will be closed to the                                         Agenda: To review and evaluate grant                          Anna Snouffer,
                                               public in accordance with the                                              applications.                                                   Deputy Director, Office of Federal Advisory
                                               provisions set forth in sections                                             Place: Hilton Washington/Rockville, 1750                      Committee Policy.
                                               552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                                 Rockville Pike, Rockville, MD 20852.
                                                                                                                            Contact Person: Patrick K. Lai, Ph.D.,                        [FR Doc. 2015–03936 Filed 2–25–15; 8:45 am]
                                               as amended. The grant applications and
                                               the discussions could disclose                                             Scientific Review Officer, Center for                           BILLING CODE 4140–01–P
rmajette on DSK2VPTVN1PROD with NOTICES




                                                                                                                          Scientific Review, National Institutes of
                                               confidential trade secrets or commercial
                                                                                                                          Health, 6701 Rockledge Drive, Room 2215,
                                               property such as patentable material,                                      MSC 7812, Bethesda, MD 20892, 301–435–
                                               and personal information concerning                                        1052, laip@csr.nih.gov.
                                               individuals associated with the grant                                        Name of Committee: Center for Scientific
                                               applications, the disclosure of which                                      Review Special Emphasis Panel,
                                               would constitute a clearly unwarranted                                     Fellowships: Risk, Prevention and Health
                                               invasion of personal privacy.                                              Behavior.



                                          VerDate Sep<11>2014         15:27 Feb 25, 2015         Jkt 235001       PO 00000       Frm 00041        Fmt 4703       Sfmt 9990   E:\FR\FM\26FEN1.SGM   26FEN1



Document Created: 2015-12-18 13:05:11
Document Modified: 2015-12-18 13:05:11
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 18, 2015.
FR Citation80 FR 10495 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR